1. Home
  2. EVTL vs TLSA Comparison

EVTL vs TLSA Comparison

Compare EVTL & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

HOLD

Current Price

$2.20

Market Cap

206.7M

Sector

Industrials

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.27

Market Cap

155.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTL
TLSA
Founded
2016
2013
Country
United Kingdom
United Kingdom
Employees
454
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
206.7M
155.2M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
EVTL
TLSA
Price
$2.20
$1.27
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$12.50
N/A
AVG Volume (30 Days)
2.0M
141.1K
Earning Date
03-24-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.90
$0.73
52 Week High
$7.60
$2.60

Technical Indicators

Market Signals
Indicator
EVTL
TLSA
Relative Strength Index (RSI) 22.80 46.51
Support Level N/A N/A
Resistance Level $4.80 $1.62
Average True Range (ATR) 0.32 0.12
MACD -0.12 -0.00
Stochastic Oscillator 15.55 36.84

Price Performance

Historical Comparison
EVTL
TLSA

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.

Share on Social Networks: